EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Clinical trials for EXUDATIVE AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new EXUDATIVE AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for EXUDATIVE AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for wet AMD patients: fewer injections with higher dose?
Disease control Not yet recruitingThis study looks at whether a higher dose (8 mg) of the drug aflibercept can help people with wet age-related macular degeneration (AMD) go longer between eye injections. Wet AMD is a leading cause of vision loss in older adults, and current treatments often require frequent inje…
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 17, 2026 10:49 UTC
-
Can a smartphone app help wet AMD patients see better for longer?
Disease control Not yet recruitingThis study looks at whether a home monitoring app can help people with wet age-related macular degeneration (eAMD) safely extend the time between Aflibercept injections. About 80 adults already receiving this treatment will use the app and have regular eye exams over one to two y…
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
AI eye doctor: new system aims to take guesswork out of injection timing
Knowledge-focused Not yet recruitingThis study tests an AI system called FM-VEGF-CDSS that helps doctors decide the best time for anti-VEGF eye injections in people with wet age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. The AI looks at eye scans and medical records to suggest …
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC